{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:46:19Z","timestamp":1792759579423,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111805","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:51:45Z","timestamp":1709794305000},"page":"111805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization"],"prefix":"10.1016","volume":"130","author":[{"given":"Jingwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyue","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9997","key":"10.1016\/j.intimp.2024.111805_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2024.111805_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in african americans: results from a population-based study","volume":"52","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"10.1016\/j.intimp.2024.111805_b0015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2024.111805_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111293","article-title":"Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2\/iNOS signaling in peripheral myeloid and CD4 + T cells","volume":"126","author":"Alfardan","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.111805_b0025","article-title":"Therapeutic effects of candesartan in inflammatory skin disorders by suppressing Th17 differentiation","volume":"124","author":"Son","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111805_b0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2022.04.027","article-title":"Single-cell analysis implicates T(H)17-to-T(H)2 cell plasticity in the pathogenesis of palmoplantar pustulosis","volume":"150","author":"McCluskey","year":"2022","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111805_b0035","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10753-023-01883-6","article-title":"Low-dose Interleukin-2 for psoriasis therapy based on the regulation of Th17\/Treg cell balance in peripheral blood","volume":"46","author":"Qiao","year":"2023","journal-title":"Inflammation."},{"issue":"32","key":"10.1016\/j.intimp.2024.111805_b0040","doi-asserted-by":"crossref","first-page":"19408","DOI":"10.1073\/pnas.2005010117","article-title":"CD4 T cell-intrinsic role for the T helper 17 signature cytokine IL-17: effector resistance to immune suppression","volume":"117","author":"Crawford","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2024.111805_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104751","article-title":"A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases","volume":"95","author":"Ni","year":"2023","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.intimp.2024.111805_b0050","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","article-title":"Obesity-induced dysregulation of skin-resident PPAR\u03b3(+) treg cells promotes IL-17A-mediated psoriatic inflammation","volume":"56","author":"Sivasami","year":"2023","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2024.111805_b0055","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.intimp.2024.111805_b0060","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","article-title":"Interleukin-1-inducible genes in endothelial cells. cloning of a new gene related to C-reactive protein and serum amyloid P component","volume":"267","author":"Breviario","year":"1992","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.intimp.2024.111805_b0065","doi-asserted-by":"crossref","first-page":"25584","DOI":"10.1074\/jbc.270.43.25584","article-title":"Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor\/interleukin-1-inducible pentraxin protein","volume":"270","author":"Altmeyer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2024.111805_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"5701","key":"10.1016\/j.intimp.2024.111805_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/278259a0","article-title":"Serum amyloid P-component is an acute-phase reactant in the mouse","volume":"278","author":"Pepys","year":"1979","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2024.111805_b0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-022-04962-y","article-title":"Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32","volume":"13","author":"Yin","year":"2022","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.intimp.2024.111805_b0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2014.02.015","article-title":"The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection","volume":"40","author":"Jaillon","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2024.111805_b0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a humoral pattern recognition molecule, innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol Rev"},{"issue":"41","key":"10.1016\/j.intimp.2024.111805_b0095","doi-asserted-by":"crossref","first-page":"28263","DOI":"10.1074\/jbc.M109.009225","article-title":"Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition","volume":"284","author":"Ma","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.intimp.2024.111805_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","article-title":"Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19","volume":"22","author":"Brunetta","year":"2021","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2024.111805_b0105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cell.2015.01.004","article-title":"PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer","volume":"160","author":"Bonavita","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2024.111805_b0110","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.7150\/ijms.54787","article-title":"Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past","volume":"18","author":"Qiu","year":"2021","journal-title":"Int J Med Sci"},{"issue":"4","key":"10.1016\/j.intimp.2024.111805_b0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2024.111805_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102163","article-title":"Pentraxin 3: a promising therapeutic target for cardiovascular diseases","volume":"93","author":"Ye","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"6912","key":"10.1016\/j.intimp.2024.111805_b0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2024.111805_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108513","article-title":"The long pentraxin 3 (PTX3) suppresses immunity to cutaneous leishmaniasis by regulating CD4(+) T helper cell response","volume":"33","author":"Gupta","year":"2020","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.intimp.2024.111805_b0135","first-page":"415","article-title":"Long pentraxin 3: a marker of inflammation in untreated psoriatic patients","volume":"18","author":"Bevelacqua","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.intimp.2024.111805_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113783","article-title":"Molecular insight into pentraxin-3: update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role","volume":"156","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.intimp.2024.111805_b0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2018.00417","article-title":"The long pentraxin 3 plays a role in bone turnover and repair","volume":"9","author":"Gr\u010devi\u0107","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.intimp.2024.111805_b0150","doi-asserted-by":"crossref","first-page":"e3125","DOI":"10.1038\/cddis.2017.514","article-title":"Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis","volume":"8","author":"Scimeca","year":"2017","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.intimp.2024.111805_b0155","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2024.111805_b0160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144363","article-title":"Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor","volume":"132","author":"Godsel","year":"2022","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.intimp.2024.111805_b0165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1523-1755.2005.67111.x","article-title":"Human renal epithelial cells produce the long pentraxin PTX3","volume":"67","author":"Nauta","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.intimp.2024.111805_b0170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78601","article-title":"Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3","volume":"12","author":"Porte","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2024.111805_b0175","article-title":"The long pentraxin PTX3 as a new biomarker and pharmacological target in age-related macular degeneration and diabetic retinopathy","volume":"12","author":"Stravalaci","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2024.111805_b0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2024.111805_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s44318-024-00040-5","article-title":"Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB\/IRF3 activation promotes antitumor immunity in prostate cancer","author":"Alaimo","year":"2024","journal-title":"Embo j"},{"key":"10.1016\/j.intimp.2024.111805_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110628","article-title":"Pentraxin 3 inhibits fibroblast growth factor 2 induced osteoclastogenesis in rheumatoid arthritis","volume":"131","author":"Zhao","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.intimp.2024.111805_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2015.07.002","article-title":"Long-pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy","volume":"28","author":"Ronca","year":"2015","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.intimp.2024.111805_b0200","doi-asserted-by":"crossref","first-page":"17681","DOI":"10.1074\/jbc.M109.085639","article-title":"The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2","volume":"285","author":"Inforzato","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.intimp.2024.111805_b0205","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41467-022-28657-2","article-title":"Menin directs regionalized decidual transformation through epigenetically setting PTX3 to balance FGF and BMP signaling","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.intimp.2024.111805_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103167","article-title":"IL-23 induces CLEC5A(+) IL-17A(+) neutrophils and elicit skin inflammation associated with psoriatic arthritis","volume":"143","author":"Furuya","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.intimp.2024.111805_b0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2023.08.001","article-title":"Pentraxin 3 deficiency ameliorates the severity of osteoarthritis and alleviates inflammation","volume":"677","author":"Qiu","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.intimp.2024.111805_b0220","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111805_b0225","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.intimp.2024.111805_b0230","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-022-00720-0","article-title":"Deucravacitinib for the treatment of psoriatic disease","volume":"23","author":"L\u00e9","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.intimp.2024.111805_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112910","article-title":"SLC38A5 aggravates DC-mediated psoriasiform skin inflammation via potentiating lysosomal acidification","volume":"42","author":"Zhu","year":"2023","journal-title":"Cell Rep"},{"issue":"22","key":"10.1016\/j.intimp.2024.111805_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216095","article-title":"Inflammation and psoriasis: a comprehensive review","volume":"24","author":"Man","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.intimp.2024.111805_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107229","article-title":"Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway","volume":"94","author":"Zhao","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.intimp.2024.111805_b0250","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"18","author":"Schett","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111805_b0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12931-020-01499-6","article-title":"Pentraxin 3 promotes airway inflammation in experimental asthma","volume":"21","author":"Gao","year":"2020","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.intimp.2024.111805_b0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cid\/ciu337","article-title":"Immune correlates of protection in human invasive aspergillosis","volume":"59","author":"Camargo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2024.111805_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2023.09.004","article-title":"Keratinocyte derived HMGB1 aggravates psoriasis dermatitis via facilitating inflammatory polarization of macrophages and hyperproliferation of keratinocyte","volume":"163","author":"Chen","year":"2023","journal-title":"Mol Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2024.111805_b0270","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI29441","article-title":"Misbehaving macrophages in the pathogenesis of psoriasis","volume":"116","author":"Clark","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2024.111805_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941071","article-title":"Dendritic cells and macrophages in the pathogenesis of psoriasis","volume":"13","author":"Kamata","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2024.111805_b0280","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jdermsci.2018.05.009","article-title":"Treatment with TNF-\u03b1 inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation","volume":"91","author":"Lin","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.intimp.2024.111805_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117231","article-title":"PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization","volume":"243","author":"Li","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.intimp.2024.111805_b0290","doi-asserted-by":"crossref","first-page":"6656622","DOI":"10.1155\/2021\/6656622","article-title":"Profiles of innate immune cell infiltration and related Core genes in psoriasis","volume":"2021","author":"Gong","year":"2021","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.intimp.2024.111805_b0295","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1038\/s41467-023-43219-w","article-title":"RNA m(6)A methylation modulates airway inflammation in allergic asthma via PTX3-dependent macrophage homeostasis","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924003230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924003230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:17:43Z","timestamp":1761589063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924003230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":59,"alternative-id":["S1567576924003230"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111805","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111805"}}